Studies have reported high PSAP expression in clinical glioma specimens, glioma-stem cells and cell-lines [62, 63] with PSAP expression and secretion highest in mesenchymal tumours, the most aggressive transcriptional subtype of GBM [64]. Here, PSAP is linked to central nervous system cancer.